The effects of metformin and rosiglitazone on heart rate variability in type 2 diabetes mellitus
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
No studies have comprehensively assessed the role of the most common variables, such as age, gender, blood glucose control, or medications treating for T2DM, on HRV parameters.
“Furthermore, despite HRV being linked with the severity of T2DM [23], no studies have comprehensively assessed the role of the most common variables, such as age [24], gender [25], blood glucose control [26], or medications treating for T2DM, on HRV parameters [27,28].”
From Heart rate variability in type 2 diabetes mellitus: A systematic review and meta–analysis (2018) · cites this paper as [27]
Cited by
Sorted by citations
Heart rate variability in type 2 diabetes mellitus: A systematic review and meta–analysis
Benichou, T., Pereira, B., Mermillod, M., Tauveron, I., Pfabigan, D., Maqdasy, S., & Dutheil, F. (2018) · PLOS ONE · doi:10.1371/journal.pone.0195166 · Cited by 419 · see citing works
- Authors
- Kilit, C., Demir, S., Pasali Kilit, T., & Melek, M.
- Affiliations
- Afyon Kocatepe University (TR)
- ORCID
- Melek, Mehmet
- Venue
- Journal of Electrocardiology
- Publisher
- Elsevier BV
- Published
- 2007-07
- Volume
- 40
- Issue
- 4
- Pages
- S40-S41
- ISSN
- 0022-0736 (ISSN-L)
- OpenAlex
- W4246612239
- Cited by
- 1
- References
- 0
- Citations by year
- 2018: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Electrocardiology (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- metformin, rosiglitazone, heart rate variability, type 2 diabetes, antidiabetic drugs, cardiac autonomic function, risk stratification
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
